Time to and Level of Initial DAS28 Change With Certolizumab Pegol Predicts the Likelihood of Having Low Disease Activity at Years 1 and 2 in Patients With Rheumatoid Arthritis
Author(s):
Haraoui, B.; Heijde, D. van der; Schiff, M.; Keystone, E.; Landewe, R.; Kvien, T.; Curtis, J.; Khanna, D.; Luijtens, K.; Furst, D.
